Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2007

Conditions
Carcinoma of Unknown PrimaryPain
Interventions
DRUG

gemcitabine hydrochloride

PROCEDURE

quality-of-life assessment

Trial Locations (37)

10466

Our Lady of Mercy Medical Center Comprehensive Cancer Center, The Bronx

43015

Grady Memorial Hospital, Delaware

43055

Licking Memorial Cancer Care Program at Licking Memorial Hospital, Newark

43081

Mount Carmel St. Ann's Cancer Center, Westerville

43130

Fairfield Medical Center, Lancaster

43215

CCOP - Columbus, Columbus

Grant Medical Center Cancer Care, Columbus

43222

Mount Carmel Health - West Hospital, Columbus

43228

Doctors Hospital at Ohio Health, Columbus

43701

Genesis - Good Samaritan Hospital, Zanesville

44708

Mercy Cancer Center at Mercy Medical Center, Canton

45504

Mercy Medical Center, Springfield

45505

Community Hospital of Springfield and Clark County, Springfield

45601

Adena Regional Medical Center, Chillicothe

45750

Strecker Cancer Center at Marietta Memorial Hospital, Marietta

45801

St. Rita's Medical Center, Lima

46350

Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte

46515

Elkhart General Hospital, Elkhart

46601

CCOP - Northern Indiana CR Consortium, South Bend

Memorial Hospital of South Bend, South Bend

46617

Saint Joseph Regional Medical Center, South Bend

46904

Howard Community Hospital, Kokomo

49001

Borgess Medical Center, Kalamazoo

49007

Bronson Methodist Hospital, Kalamazoo

49085

Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph

50010

McFarland Clinic, PC, Ames

54601

Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse

60521

Hinsdale Hematology Oncology Associates, Hinsdale

60612

Veterans Affairs Medical Center - Chicago Westside Hospital, Chicago

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

60612-7243

University of Illinois Cancer Center, Chicago

62781-0001

Regional Cancer Center at Memorial Medical Center, Springfield

49007-3731

West Michigan Cancer Center, Kalamazoo

08053

Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton, Marlton

08043

Fox Chase Virtua Health Cancer Program at Virtua West Jersey, Voorhees Township

44106-5065

Case Comprehensive Cancer Center, Cleveland

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00357630 - Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary | Biotech Hunter | Biotech Hunter